In-depth trading ideas

Discover detailed market analysis from traders. See how others approach this instrument, compare different strategies, and discover perspectives that can shape your own view.

CSL — The Flush Before the Recovery?CSL — The Flush Before the Recovery? CSL is one of Australia’s heavyweight blue-chips, so this is a big map for me. Technically, price is still recovering inside a damaged higher-timeframe structure, and I’m watching the current rally as a push into resistance rather than a confirmed new bull leg. Short around $176 → TP $113 That lower target sits in the deeper structural reset area on my map. If price reaches it and buyers defend the zone, that is where I switch sides. Long $113 → TP1 $1

CSL Undervalue Gem That Will Rebound CSL Limited (ASX:CSL) has long been considered one of Australia’s premier healthcare stocks, yet recent trading levels suggest it is undervalued relative to its historical benchmarks. Currently hovering around A$100, CSL is priced well below analyst fair value estimates of A$155, reflecting a discount of roughly 36%. This gap is largely due to FY26 earnings pressure, including US$5 billion in impairments tied to CSL Vifor and restructuring charges that temporarily obscure the strength of its pla

by danny_peanuts

CSL Grand Supercycle Correction Over?They used to say "never sell CSL", they were right up until it peaked on March 2020. This was at the height of the Covid dump, whilst other stocks crashed; CSL was putting in a supercycle top. If you didn't sell the top, you are now down 72% since the all time high. Ouch! CSL is not any old stock, this is a leader in the ASX, one of the greatest businesses out of Australia. I was closely looking at this stock less than a year ago, fortunately I only purchased a tracker share and didn't pull the

CSL Limited (ASX:CSL)One of the strongest “moat” businesses on the ASX because it operates in a niche of healthcare that is extremely difficult, expensive, and slow for competitors to replicate. 1. Plasma collection network (huge barrier to entry) CSL is one of only a few global companies dominating plasma-derived therapies. Morningstar describes it as a highly consolidated oligopoly. A new competitor cannot easily “just enter” the market. - Plasma medicines require human plasma donations - CSL owns hundreds of

CSL GOES "SHAKE IT. BAKE IT. BOOTY QUAKE IT. ROLL IT AROUND".CSL Ltd is an Australian multinational specialty biotechnology company that researches, develops, manufactures, and markets products to treat and prevent serious human medical conditions. CSL's product areas include blood plasma derivatives, vaccines, antivenom, and cell culture reagents used in various medical and genetic research and manufacturing applications. The company was established in 1916 as Commonwealth Serum Laboratories and was wholly owned by the Australian federal government unti

by PandorraResearch

Epic Grand Supercycle Correction We are witnessing an epic grand supercycle correction in one of the best performing stocks over the last couple of decades. This stock went vertical for 14 years, but what goes up must come down. This stock is owned by many Australian investors, I understand it to be a top 5 name in the Australian stock exchange, a crown jewel in their biotech industry. This stock peaked in February 2020, as the Covid crash was starting to unravel. The massive drive to produce vaccines kept this stock going. R

Never Sell CSL?In the Australian stock market, for years and years there was a saying: “Never sell CSL.” This informal mantra was common among investors and brokers and reflected CSL Limited’s reputation as a blue-chip, defensive, growth-and-dividend stock. The idea was that CSL’s business in plasma-derived therapies and vaccines was extremely stable, high-quality, and consistently growing, making selling the stock almost unthinkable. Key reasons behind the saying: CSL had strong, predictable earnings

Time to enter ASX:CSL ⁉️Last week, CSL management received positive feedback and the stock is currently in a base. While there is no confirmation of a new trend, the risk-reward ratio is favorable to add a small amount and let the market guide for further additions. I will only add up to 50% of my position in the low base, so if the stock fails to reach its all-time high, I will still have some gains to take away. The stock symbol is $ASX:CSL. Disclosure: I am investing in my super account for the first trance I can

by Peaceful-Weekend-Investing

Australias CSL Trading in a range on the monthly.Not one I am personally trading at the moment, but CSL was one of the most reliable stocks on the Australian market for years. Since 2020 though it has been stuck in this sideways range that could be good for the worlds slowest swing trade :) Being towards the bottom of the range might mean there is some upside on the table if the ASX is a market you trade.

CSL at support?Looks like a good buying opportunity for CSL at previous support. Broader economic downturn may invalidate this trade.

CSL down? stock perhaps overvalued, going to short at the OB down or get stopped.

CSL looking unwell So... my previous bullish attempt at this pattern failed, and I am now looking at the bearish play. A rising wedge pattern, looking to break from the rising support line. If this plays out, then the target will be around $248. The target is supported by the height of wedge, fair value gap and fib level, so looks to be a very strong possibility. The bearish sentiment is also supported by the disruptions to CSL business (Vifor), a higher cost environment, interest rates rises and latest drop in di

CSL 3WK Analysis CSL is showing weak strength. Possible reversal from 3WK trendline. Expect price to move to 282. It could also touch strong support at 242 zone

by tradinghill_1

CSL breaking ascending triangle Was watching this for a while. It just popped. Missed entry yesterday, but will wait for a re-test to enter. Entry at $309 for a target of $334. SL @ $307. DYOR and trade at own risk.

Analysis: two possibilities On this stock we will have a reversal trend if we have the breakout with strenght the vwap indicator and the resistance line by a big green candle with a large green volume. In other hand we could have a downtrend continuity if we have the breakout with strenght the vwap indicator and the support line by a big red candle with a large red volume.Thanks.

CSL Testing highs Above upward sloping 20, 50 sma RSI above 50 Macd positive and above signal line Target conservative previous highs

by Advanced_Analyst

CSL.ASX_Bullish Breakout Trade_Long ENTRY: 299.20 SL: 285.64 TP: 317.82 - ADX<25. Would like to be higher. - Daily RS +ve - Daily FFI +ve - Weekly RS +ve - Weekly FFI +ve - Moving averages are aligned. - Breakout of consolidation area on 6 Jul 2022 before going into another consolidation range. - Recovered well on 17 Aug 2022 after earnings indicating possible buyers still in play. - Entry today based on breakout and rebound off 10EMA and 20EMA with volume. Would like the rebound to be >3%.

by TRADER-WANNA-BE

CSL Australia SSI Live Trading Series Sun Storm Investment Trading Desk & NexGen Wealth Management Service Present's Focus: Worldwide By Sun Storm Investment Research & NexGen Wealth Management Service A Profit & Solutions Strategy & Research Trading | Investment | Stocks | ETF | Mutual Funds | Crypto | Bonds | Options | Dividend | Futures | USA | Canada | UK | Germany | France | Italy | Rest of Europe | Mexico | India Disclaimer: Sun Storm Investment and NexGen are not registered financial advis

by Sunstorminvest

CSL Australia Sun Storm Investment Trading Desk & NexGen Wealth Management Service Present's: SSITD & NexGen Portfolio of the Week Series Focus: Worldwide By Sun Storm Investment Research & NexGen Wealth Management Service A Profit & Solutions Strategy & Research Trading | Investment | Stocks | ETF | Mutual Funds | Crypto | Bonds | Options | Dividend | Futures | USA | Canada | UK | Germany | France | Italy | Rest of Europe | Mexico | India Disclaimer: Sun Storm Investment and NexGen are not regist

by Sunstorminvest

CSL for a breakout & grind higher on improving fundamentals CSL is seeing improved plasma collection as places like the US start to return to normal. Additionally the Vifor acquisition should complete in the next few months with the potential for the stock to re-rate higher. The stock has formed an ascending triangle formation with resistance being tested on multiple occasions at the 273/274 level at which a major stock placement to fund the Vifor acquisition was recently conducted. A breakout at 274 was observed with the stock pulling back to retest tha

At what Price am I looking at CSL again ?CSL charts suggest that the price action is looking for a support zone and if it eventuates the $200 - $230 range would be a great spot to pick it up for a long term hold.

CSL Sideways Move, Break Up or Down CSL seems to have been moving Side ways from the high of $335 on the 17th Feb 2020, Resistance seems to be set around the $315 - $320 Mark with the market trying to push through this level on 4 occasions; 17th August 2020, 30th November 2020, 30th August 2021, and recently 22nd November 2022. From the RSI and MACD indicator below and the the bearish trend of the Overall market, I feel resistance level for CSL will remain the $415-$320 Mark. I have drawn the current support level at the $270 mark

Boomer Stock Down...Premium Blue Chip Boomer stock appears to be in the bull trap stage, this is all relative to my view of another global crash.